Fact CheckerSign in

NCT05092009Active, not recruiting

Lung Cancer Organoids and Patient Derived Tumor Xenografts

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

Extra tissue will be taken from patient during a procedure in standard of care. Also, through an existing line, 10ml of extra blood will be drawn. From this material the investigator will try to establish matched normal and primary human lung cancer organoids.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
15 Sept 2021
Start date
5 Oct 2022
Primary completion date
1 Oct 2026
Lead sponsor
Maastricht Radiation Oncology
Diseases
Lung cancer
NCT number
NCT05092009

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 5 Oct 2022 to the primary completion date, 1 Oct 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • There are no exclusion criteria

Who the study is looking for

  • All patients selected to undergo primary surgical resection of a primary lung cancer. All types of resection are eligible, e.g. wedge resection, segmental resection, lobectomy, pneumonectomy.
  • All patients with (suspected) lung cancer that will undergo a bronchoscopy or endobronchial ultrasound guided transbronchial needle aspiration (EBUS/EUS-TBNA) bronchoscopy.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Zuyderland Medical Center
Coordinator of this site? Confirm its status
HeerlenNetherlandsUnknown status
Maastricht Radiation Oncology (Maastro)
Coordinator of this site? Confirm its status
MaastrichtNetherlandsUnknown status
MUMC+
Coordinator of this site? Confirm its status
MaastrichtNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.